The reengineering of laboratories and laboratory processes should consider the need for optimizing and improving qualitycontrol (QC) practices and procedures. 4 Advanced automation will require the development of innovative process control systems that provide on-line decisions to release patient test results, repeat analyses of patient specimens, requalify the quality of testing processes, deactivate poorly performing instrument systems, and maximize the cost-effective operation of the testing process. Provision of these capabilities will require carefully designed control procedures that optimize the detection of medically important errors, minimize false rejections, and maximize the length of the analytical run. The development of QC planning tools, such as power function graphs, critical-error graphs, and charts of operating specifications (OPSpecs charts) [1, 2] , facilitate the selection of control rules and numbers of control measurements on the basis of the observed imprecision and inaccuracy of a measurement procedure and the analytical or clinical quality that is required for the particular test [3, 4] . Recent studies illustrate the practical application of OPSpecs charts for selecting QC procedures for a variety of immunoassays [5] . Earlier work demonstrated the application of other QC planning tools (power function and critical-error graph) for selecting QC procedures for a multitest chemistry analyzer [6] . Thus, a systematic QC planning process and graphical QC planning tools are now available to optimize the detection of medically important errors and minimize false rejections of analytical runs.
Unfortunately, there has been little progress in developing a rational method for maximizing the length of the analytical run. [7] , which provides the following definition of analytical run: For purposes of quality control, an analytical run is an interval (i.e., a period of time or series of measurements) within which the accuracy and precision of the measuring system is expected to be stable. Between analytical runs, events may occur causing the measurement process to be susceptible to variations that are important to detect. If it were possible to use patients' test results to monitor "variations that are important to detect," then the length of an analytical run could be measured objectively.
The attempted use of patient test data to monitor system performance has a long history in healthcare laboratories. In 1965, Hoffman and Waid [8] introduced the average of normals (AON) QC method, in which the test results of a group of patient specimens falling within the "normal" range were averaged, then the average used to monitor changes in the testing process. The performance of such AON procedures were evaluated in laboratories by several investigators during the 1970s, leading to contradictory findings and recommendations about the practical usefulness of such procedures. In 1984, Gembrowski et al. [9] assessed the expected performance using computer simulation to develop power curves that described the probability of rejecting runs as a function of the size of systematic error occurring in the testing process. Cembrowski demonstrated that the power for detecting systematic changes in the mean of patient tests depended on the ratio of population to analytical standard deviations, the width of the truncation limits, the number of patient test results available after truncation, and the width of the control limits for the mean patient value.
Given that power functions can be determined for AON procedures, it should be possible to apply the available QC planning tools to design AON procedures that will detect medically important systematic errors and provide a signal when the stability of the analytical run requires verification.
In this paper, we describe how AON procedures can be designed to provide the error detection needed to monitor the length of an analytical run.
Materials and Methods

POWER CURVES FOR AON PROCEDURES
Computer simulation studies were performed in the manner described earlier by Cembrowski et al. [9] Fig. 1 shows an OPSpecs chart for AON algorithms having n from 200 to 20, which are represented by the lines from top to bottom. The observed imprecision and inaccuracy are shown by the operating point. An effective AON algorithm is one whose allowable limits of inaccuracy and imprecision are above the operating point. The solid line identifies an AON algorithm with n = 60 as being appropriate for this application. Given a test that has a different s,0/s,035 ratio of 9 but the same analytical quality requirement and the same observed imprecision and observed inaccuracy, the AON algorithm requires 180 patient test results to effectively monitor the stability of the analytical run. Fig. 3 shows an OPSpecs chart for n from 450 to 60, as represented by the lines from top to bottom. The observed imprecision and inaccuracy are again shown by the operating point and the solid line identifies the AON algorithm with n = 180 as being appropriate for this application. provides comparable information in the form of the criticalerror graph for systematic error. total triiodothyronine (T3), T3 uptake, and urate (Table 1) . For most of these tests, an increased daily workload would make AON procedures more useful, permitting stability to be monitored during daily runs. AON algorithms would not be expected to be useful for monitoring run length for tests such as amylase, total and HDL cholesterol, creatine kinase (CK), FSH, lipase, lutropin (LH), prolactin, total protein, total T4, triglyceride, or vitamin B1, (Table 1) . For some of these tests, the Ontario LPTP criteria are more demanding than the US CLIA criteria (e.g., 15% vs 30% for amylase and CK, 5% vs 10% for total and HDL cholesterol and total protein, 5% vs 25% for triglyceride), thus again pointing out the need to assess the performance of AON algorithms for each laboratory on the basis of the quality requirements it needs to satisfy and the performance being achieved by its methods.
Results
Discussion
AON algorithms can be designed to monitor the stability of tests and systems, with the objective of providing statistical evidence of instability to signal the end of a stable period of operation, or the end of an analytical run. The amount of instability that can be allowed before ending an analytical run is the critical systematic error calculated from the TEa and the observed imprecision(s,,ca) and inaccuracy (biasn,eas) of the measurement procedure.
This instability can be detected by AON algorithms that depend on the ratio of the population and analytical standard deviations (Sp,,1,/S,,,eas) for the particular test and include an appropriate number of patient samples (n). OPSpecs charts and critical-error graphs. As laboratories reengineer their testing processes and move towards higher levels of automation, improved process control software will be critically needed to assure both the quality of laboratory test results and the productivity of laboratory testing processes. A recent College of American Pathologists Q-Probe on laboratory QC practices [14) revealed that most laboratories are using the same QC practices now as 10 years ago. These QC practices, which are already outdated by the introduction of one or two generations of newer analytical systems, need to be improved to balance the error detection and false rejection characteristics of statistical QC procedures, as well as to minimize the number of control measurements and maximize the number of patient samples in an analytical run. Improved process control software will be necessary to support this optimization and also to implement improved QC designs for individual tests performed by multitest systems. In the future, process control software may evolve into the next-generation laboratory information system because it will provide active control of analytical systems for the purpose of acquiring high-quality patient test results at low cost. High quality will mean accurate test results with as short turnaround time as possible; low cost will mean effective utilization of available testing processes and associated laboratory resources. To achieve high quality and low cost, laboratories will have to develop more quantitative approaches for managing the quality and productivity of their testing processes. Improved management should include careful selection of the statistical control rules and numbers of control measurements for stable control materials and careful application of AON algorithms to utilize patient data for maximizing the length of the analytical run.
